Cardiovascular DiseasesNCT00139490
Home-Based Program to Treat High Blood Pressure in African Americans
A study testing Health Education Program and Basic Group in people with Cardiovascular Diseases and Heart Diseases, run by Visiting Nurse Service of New York.
Trial summary
The purpose of this study is to examine the effectiveness and cost effectiveness of two organizational interventions aimed at improving blood pressure (BP) control among a high-risk, African American home care population. Read more about this study
- Who is it for?
- Ages 21 to 79 years
- Conditions the study is for
- Cardiovascular Diseases, Heart Diseases, Hypertension
- What is being tested?
- Health Education Program and Basic Group
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- Yes, some participants may receive a placebo
- How many people
- 846 participants
- Where
- No sites listed yet
- Study dates
- Feb 2006to Sep 2009
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 21 to 79 years
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- African American
- Have uncontrolled hypertension, defined as BP greater than 140/90 mm Hg (systolic, diastolic, or both), and 130/80 mm Hg for individuals with diabetes or kidney failure
Who cannot join
- Severe heart failure
- Moderate to severe cognitive impairment
- Overall "poor" or "guarded" prognosis
- Life expectancy of less than 6 months from study entry
About this study
Official title: Home-Based Blood Pressure Interventions for African Americans
The purpose of this study is to examine the effectiveness and cost effectiveness of two organizational interventions aimed at improving blood pressure (BP) control among a high-risk, African American home care population.
Read the detailed description
BACKGROUND:
Home health care is a non-institutional, "diverse health care setting" that provides services to a high-risk population characterized by multiple chronic conditions and significant needs for both medical and self-care management. Home health agencies discharged approximately 7.6 million patients in 1998, of whom approximately 60 to 65% were female and 12 to 15% black (US DHHS 2000; Haupt 1998). Home health patients are clinically diverse. Individuals with conditions of the circulatory system comprise the single largest share (about 22% in 1996) (Haupt 1998), while heart failure (I-IF), diabetes, chronic obstructive pulmonary disease, and essential hypertension (HTN) are patients' most frequent primary diagnoses (Haupt \& Jones 1999). Most home health patients enter care after a hospitalization and more than two-thirds are discharged to the community. Management of HTN has not been a high priority for guideline adoption or quality improvement activities in home health care (Peterson 2004), even though approximately 8% of home care patients are admitted with essential HTN as a first, second, or third diagnosis (Haupt \& Jones, 1999). In the words of one clinical nurse specialist, home health nurses tend to see elevated BP readings as "a set of numbers rather than a condition to be managed," despite the fact that their patients may be at high risk of future HTN-related complications by virtue of their comorbidities and history of prior hospitalization.
Teaching patients about their conditions, promoting patient self-management, helping patients adhere to medical regimens established by their physicians, and linking them to community resources are central to the role of the home health nurse (Clemen-Stone et al. 2002). However, with the advent of a home health prospective payment system, nurses are working under heightened pressure to constrain service use and reduce time in the patient's home. This pressure, in turn, may provide a disincentive to focus on high BP management issues, particularly when HTN is a second or third diagnosis and not the primary reason for which a person has been admitted to home care. Thus home health care represents a segment of the health care system where a significant number of high-risk HTN patients are served, where HTN practice likely requires significant improvement, and where nursing personnel are uniquely positioned to mobilize their care management and patient education skills to increase the proportion of treated HTN patients who achieve adequate BP control. The underlying premise of the project is that organizational change to improve BP management and outcomes will not easily occur in home health care without new intervention models, rigorous evaluation of their impact, or efforts by opinion leaders in the clinical and research communities to disseminate information on strategies that are efficacious and cost-effective. Visiting Nurse Service of New York (VNSNY), serving over 70,000 adult patients per year, provides a prominent organizational "laboratory" for testing promising new models of care.
The study is in response to a Request for Applications released in September 2003 on "Interventions to Improve Hypertension Control Rates in African Americans."
DESIGN NARRATIVE:
The study will enroll African American patients with uncontrolled hypertension who are entering the home care program of the VNSNY. It will employ a randomized design, whereby all VNSNY nurses who are providing direct care to the eligible study population (an estimated 300 nurses serving an estimated 1000 African American patients with uncontrolled hypertension) will be randomly assigned to a control group or one of two intervention groups upon identification of the first eligible hypertensive patient to whom they provide care during the study period. Throughout the study, each nurse will continue to administer the same intervention, either usual care, basic intervention, or an augmented intervention, so that randomization will be by nurse, rather than by patient. A nurse's initial random assignment to a specific group (usual care, basic treatment, or augmented treatment) will determine the status for all new patients allocated to that particular nurse's care for the duration of the study.
The two interventions to be tested include the following: 1) a "basic" intervention delivering key evidence-based information to nurses, physicians, and patients while the patient is receiving traditional post-acute home health care; and 2) an "augmented" intervention transitioning patients to a Home-Based HTN Support Program that extends the information, monitoring, and feedback available to patients and primary care physicians for a 12-month period beyond an index home care admission. The interventions will be assessed relative to usual care and to each other. The analysis will estimate the impact of the basic and augmented interventions on nursing practices and processes of care, patient hypertension management (e.g., medication adherence), BP outcomes, and overall costs. Behaviors and outcomes will be measured at fixed points in time. Measures will be derived from a combination of primary and secondary data, including patient records, patient assessment instruments, patient interviews, home BP monitors, urine tests, and administrative files. Multivariate regression analyses will be conducted to determine intervention effects on study outcomes, adjusting for selected nurse and patient characteristics. Nurse level risk-adjustment will include demographics and other measures that might influence practice or processes of care, such as experience and education. Patient-level risk adjustment will include demographics, social support, and other characteristics that might influence behavior, service use, BP, or other health outcomes. Estimates of treatment-control group differences (for both treatments) generated by these models will be tested to determine the extent to which observed differences at the nurse and patient levels are attributable to the alternative intervention strategies.
- Conditions
- Cardiovascular Diseases, Heart Diseases, Hypertension
- Being tested
- Health Education Program, Basic Group, Control Group
- Keywords
- Blood Pressure, High
- Medical subject headings
- Cardiovascular Diseases, Heart Diseases, Hypertension
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Health Education ProgramBehavioural
The augmented intervention will consist of just-in-time nurse, patient and physician information and feedback during the post-acute period, plus transition to an ongoing Home-Based HTN Support Program within approximately 30 days after the patient's admission to home health care. The augmented intervention adds an HTN Nurse Specialist (advanced practice nurse) and a lay community health worker, who will be responsible for assuring a patient's smooth transition to the Home-Based HTN Support Program and for delivering the main components of that intervention, backed up by the project physician.
Basic GroupBehavioural
The basic information and referral intervention will deliver key "just-in-time" information to nurses, patients and patients' physicians while the patient is receiving post-acute home care services. The basic intervention relies on care provided by home health nurses during the routine home health stay.
Control GroupBehavioural
Usual Care
| Study group | Role | What they receive |
|---|---|---|
| A | Experimental | The augmented intervention will consist of just-in-time nurse, patient and physician information and feedback during the post-acute period, plus transition to an ongoing Home-Based HTN Support Program within approximately 30 days after the patient's admission to home health care. The augmented intervention adds an HTN Nurse Specialist (advanced practice nurse) and a lay community health worker, who will be responsible for assuring a patient's smooth transition to the Home-Based HTN Support Program and for delivering the main components of that intervention, backed up by the project physician. Receives: Behavioral: Health Education Program |
| B | Active comparator | The basic information and referral intervention will deliver key "just-in-time" information to nurses, patients and patients' physicians while the patient is receiving post-acute home care services. The basic intervention relies on care provided by home health nurses during the routine home health stay. Receives: Behavioral: Basic Group |
| C | Placebo comparator | Usual Care group Receives: Behavioral: Control Group |
What is being measured
The primary outcome is the main question the study is designed to answer.
Documented adherence to nursing-specific practices that reflect and reinforce JNC7 guidelines
Measured: Measured at 12 months
Change in systolic and diastolic BP
Measured: Measured at 12 months
Proportion of patients that are below the target home BP levels (135/85 mm Hg for non-diabetic and kidney disease participants; 125/75 mm Hg for diabetic and kidney disease participants
Measured: Measured at 12 months
Changes in systolic and diastolic Blood Pressure
Measured: Measured at 12 months
Secondary outcomes (4)
Medication adherence
Measured: Measured at 12 months
Sodium intake
Measured: Measured at 12 months
Health care utilization
Measured: Measured at 12 months
Cost-effectiveness of the program
Measured: Measured at 12 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted31 Aug 2005 (estimated)
- Study startFeb 2006
- Primary completionMay 2009
- Study completionSep 2009
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (1)Papers the sponsor has linked to this study.
- Other trials for Cardiovascular DiseasesStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 846 participants (actual)
Sponsor and investigators
- Lead sponsor
- Visiting Nurse Service of New York
- Sponsor type
- University, hospital or other
- Investigators
- Penny H. Feldman, PhD, Principal investigator, Center for Home Care Policy & Research, Visiting Nurse Service of New York
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00139490
- Sponsor's protocol ID
- 246
- Other IDs
- R01HL078585
- Status last verified
- Dec 2012
- First submitted
- 29 Aug 2005
- Last updated
- 21 Dec 2012
- Results posted
- No
- Data monitoring committee
- Yes
Publications
Feldman PH, McDonald MV, Barron Y, Gerber LM, Peng TR. Home-based interventions for black patients with uncontrolled hypertension: a cluster randomized controlled trial. J Comp Eff Res. 2016 Mar;5(2):155-68. doi: 10.2217/cer.15.60. Epub 2016 Mar 7.
PubMed 26946952
Study at a glance
From the registry record, last updated by the sponsor on 21 Dec 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Home-Based Blood Pressure Interventions for African Americans
- ClinicalTrials.gov ID
- NCT00139490
- Acronym / sponsor ID
- 246
- Conditions
- Cardiovascular Diseases, Heart Diseases, Hypertension
- Keywords
- Blood Pressure, High
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 846 participants (actual)
- Lead sponsor
- Visiting Nurse Service of New YorkUniversity, hospital or other
- Study start
- Feb 2006
- Primary completion
- May 2009 (actual)
- Study completion
- Sep 2009 (actual)
- First posted
- 31 Aug 2005 (estimated)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of this study is to examine the effectiveness and cost effectiveness of two organizational interventions aimed at improving blood pressure (BP) control among a high-risk, African American home care population.
Detailed description
BACKGROUND:
Home health care is a non-institutional, "diverse health care setting" that provides services to a high-risk population characterized by multiple chronic conditions and significant needs for both medical and self-care management. Home health agencies discharged approximately 7.6 million patients in 1998, of whom approximately 60 to 65% were female and 12 to 15% black (US DHHS 2000; Haupt 1998). Home health patients are clinically diverse. Individuals with conditions of the circulatory system comprise the single largest share (about 22% in 1996) (Haupt 1998), while heart failure (I-IF), diabetes, chronic obstructive pulmonary disease, and essential hypertension (HTN) are patients' most frequent primary diagnoses (Haupt \& Jones 1999). Most home health patients enter care after a hospitalization and more than two-thirds are discharged to the community. Management of HTN has not been a high priority for guideline adoption or quality improvement activities in home health care (Peterson 2004), even though approximately 8% of home care patients are admitted with essential HTN as a first, second, or third diagnosis (Haupt \& Jones, 1999). In the words of one clinical nurse specialist, home health nurses tend to see elevated BP readings as "a set of numbers rather than a condition to be managed," despite the fact that their patients may be at high risk of future HTN-related complications by virtue of their comorbidities and history of prior hospitalization.
Teaching patients about their conditions, promoting patient self-management, helping patients adhere to medical regimens established by their physicians, and linking them to community resources are central to the role of the home health nurse (Clemen-Stone et al. 2002). However, with the advent of a home health prospective payment system, nurses are working under heightened pressure to constrain service use and reduce time in the patient's home. This pressure, in turn, may provide a disincentive to focus on high BP management issues, particularly when HTN is a second or third diagnosis and not the primary reason for which a person has been admitted to home care. Thus home health care represents a segment of the health care system where a significant number of high-risk HTN patients are served, where HTN practice likely requires significant improvement, and where nursing personnel are uniquely positioned to mobilize their care management and patient education skills to increase the proportion of treated HTN patients who achieve adequate BP control. The underlying premise of the project is that organizational change to improve BP management and outcomes will not easily occur in home health care without new intervention models, rigorous evaluation of their impact, or efforts by opinion leaders in the clinical and research communities to disseminate information on strategies that are efficacious and cost-effective. Visiting Nurse Service of New York (VNSNY), serving over 70,000 adult patients per year, provides a prominent organizational "laboratory" for testing promising new models of care.
The study is in response to a Request for Applications released in September 2003 on "Interventions to Improve Hypertension Control Rates in African Americans."
DESIGN NARRATIVE:
The study will enroll African American patients with uncontrolled hypertension who are entering the home care program of the VNSNY. It will employ a randomized design, whereby all VNSNY nurses who are providing direct care to the eligible study population (an estimated 300 nurses serving an estimated 1000 African American patients with uncontrolled hypertension) will be randomly assigned to a control group or one of two intervention groups upon identification of the first eligible hypertensive patient to whom they provide care during the study period. Throughout the study, each nurse will continue to administer the same intervention, either usual care, basic intervention, or an augmented intervention, so that randomization will be by nurse, rather than by patient. A nurse's initial random assignment to a specific group (usual care, basic treatment, or augmented treatment) will determine the status for all new patients allocated to that particular nurse's care for the duration of the study.
The two interventions to be tested include the following: 1) a "basic" intervention delivering key evidence-based information to nurses, physicians, and patients while the patient is receiving traditional post-acute home health care; and 2) an "augmented" intervention transitioning patients to a Home-Based HTN Support Program that extends the information, monitoring, and feedback available to patients and primary care physicians for a 12-month period beyond an index home care admission. The interventions will be assessed relative to usual care and to each other. The analysis will estimate the impact of the basic and augmented interventions on nursing practices and processes of care, patient hypertension management (e.g., medication adherence), BP outcomes, and overall costs. Behaviors and outcomes will be measured at fixed points in time. Measures will be derived from a combination of primary and secondary data, including patient records, patient assessment instruments, patient interviews, home BP monitors, urine tests, and administrative files. Multivariate regression analyses will be conducted to determine intervention effects on study outcomes, adjusting for selected nurse and patient characteristics. Nurse level risk-adjustment will include demographics and other measures that might influence practice or processes of care, such as experience and education. Patient-level risk adjustment will include demographics, social support, and other characteristics that might influence behavior, service use, BP, or other health outcomes. Estimates of treatment-control group differences (for both treatments) generated by these models will be tested to determine the extent to which observed differences at the nurse and patient levels are attributable to the alternative intervention strategies.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 3
| Arm | Type | Receives |
|---|---|---|
| A | Experimental | Behavioral: Health Education ProgramThe augmented intervention will consist of just-in-time nurse, patient and physician information and feedback during the post-acute period, plus transition to an ongoing Home-Based HTN Support Program within approximately 30 days after the patient's admission to home health care. The augmented intervention adds an HTN Nurse Specialist (advanced practice nurse) and a lay community health worker, who will be responsible for assuring a patient's smooth transition to the Home-Based HTN Support Program and for delivering the main components of that intervention, backed up by the project physician. |
| B | Active comparator | Behavioral: Basic GroupThe basic information and referral intervention will deliver key "just-in-time" information to nurses, patients and patients' physicians while the patient is receiving post-acute home care services. The basic intervention relies on care provided by home health nurses during the routine home health stay. |
| C | Placebo comparator | Behavioral: Control GroupUsual Care group |
Who may qualify
- Ages
- 21 to 79 years
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (2 listed)
- African American
- Have uncontrolled hypertension, defined as BP greater than 140/90 mm Hg (systolic, diastolic, or both), and 130/80 mm Hg for individuals with diabetes or kidney failure
Key exclusion criteria (4 listed)
- Severe heart failure
- Moderate to severe cognitive impairment
- Overall "poor" or "guarded" prognosis
- Life expectancy of less than 6 months from study entry
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Health Education ProgramThe augmented intervention will consist of just-in-time nurse, patient and physician information and feedback during the post-acute period, plus transition to an ongoing Home-Based HTN Support Program within approximately 30 days after the patient's admission to home health care. The augmented intervention adds an HTN Nurse Specialist (advanced practice nurse) and a lay community health worker, who will be responsible for assuring a patient's smooth transition to the Home-Based HTN Support Program and for delivering the main components of that intervention, backed up by the project physician. | Behavioural | A |
| Basic GroupThe basic information and referral intervention will deliver key "just-in-time" information to nurses, patients and patients' physicians while the patient is receiving post-acute home care services. The basic intervention relies on care provided by home health nurses during the routine home health stay. | Behavioural | B |
| Control GroupUsual Care | Behavioural | C |
Primary outcome
Documented adherence to nursing-specific practices that reflect and reinforce JNC7 guidelines
Time frame: Measured at 12 months
Change in systolic and diastolic BP
Time frame: Measured at 12 months
Proportion of patients that are below the target home BP levels (135/85 mm Hg for non-diabetic and kidney disease participants; 125/75 mm Hg for diabetic and kidney disease participants
Time frame: Measured at 12 months
Changes in systolic and diastolic Blood Pressure
Time frame: Measured at 12 months
4 secondary outcomes
Medication adherence
Time frame: Measured at 12 months
Sodium intake
Time frame: Measured at 12 months
Health care utilization
Time frame: Measured at 12 months
Cost-effectiveness of the program
Time frame: Measured at 12 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 21 Dec 2012.
- Derived from this study: PubMed 26946952Feldman PH, McDonald MV, Barron Y, Gerber LM, Peng TR. Home-based interventions for black patients with uncontrolled hypertension: a cluster randomized controlled trial. J Comp Eff Res. 2016 Mar;5(2):155-68. doi: 10.2217/cer.15.60. Epub 2016 Mar 7.
Related trials for Cardiovascular Diseases
Active, not recruitingPhase 3
ENDOTHELION Study Group: Effect of Bosentan in NAION Patients
Ischemic Optic Neuropathy
Active, not recruiting
Digital Reinforcement of Motivational Interviewing Micro-Skills Among Primary Care Healthcare Professionals
Hypertension (Without Type 2 Diabetes Mellitus)
Not yet recruitingPhase 2
Study of YKST02 in Adults With Relapsed or Refractory Multiple Myeloma
Relapsed or Refractory Multiple Myeloma (RRMM)
RecruitingPhase 2
Engaging T-cells to Eliminate MRD in Newly Diagnosed Myeloma Optimizing Response With Talquetmab and Teclistamab (ROTATE)
Multiple Myeloma
Recruiting
PAW-Hydrogel for Chronic Wound Healing
Diabetic Foot Ulcer (DFU), Pressure Ulcer (PU)
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Penny H. Feldman, PhD principal investigator
Center for Home Care Policy & Research, Visiting Nurse Service of New York
Questions about this trial
What is this clinical trial studying?
A study testing Health Education Program and Basic Group in people with Cardiovascular Diseases and Heart Diseases, run by Visiting Nurse Service of New York.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 21 Dec 2012. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Documented adherence to nursing-specific practices that reflect and reinforce JNC7 guidelines (time frame: Measured at 12 months). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT00139490, which also lists 1 linked publication.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Dec 2012.